ID   GRAB_RAT                Reviewed;         248 AA.
AC   P18291;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=Granzyme B;
DE            EC=3.4.21.79 {ECO:0000269|PubMed:9765264};
DE   AltName: Full=Fragmentin;
DE   AltName: Full=Natural killer cell protease 1;
DE   AltName: Full=RNKP-1;
DE   Flags: Precursor;
GN   Name=Gzmb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RX   PubMed=2307850;
RA   Zunino S.J., Bleackley R.C., Martinez J., Hudig D.;
RT   "RNKP-1, a novel natural killer-associated serine protease gene cloned from
RT   RNK-16 cytotoxic lymphocytes.";
RL   J. Immunol. 144:2001-2009(1990).
RN   [2]
RP   PROTEIN SEQUENCE OF 21-53.
RX   PubMed=1727874;
RA   Sayers T.J., Wiltrout T.A., Sowder R., Munger W.L., Smyth M.J.,
RA   Henderson L.E.;
RT   "Purification of a factor from the granules of a rat natural killer cell
RT   line (RNK) that reduces tumor cell growth and changes tumor morphology.
RT   Molecular identity with a granule serine protease (RNKP-1).";
RL   J. Immunol. 148:292-300(1992).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1732416; DOI=10.1084/jem.175.2.553;
RA   Shi L., Kraut R.P., Aebersold R., Greenberg A.H.;
RT   "A natural killer cell granule protein that induces DNA fragmentation and
RT   apoptosis.";
RL   J. Exp. Med. 175:553-566(1992).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASN-102 AND ARG-229.
RX   PubMed=9765264; DOI=10.1074/jbc.273.42.27364;
RA   Harris J.L., Peterson E.P., Hudig D., Thornberry N.A., Craik C.S.;
RT   "Definition and redesign of the extended substrate specificity of granzyme
RT   B.";
RL   J. Biol. Chem. 273:27364-27373(1998).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-248 IN COMPLEX WITH E.COLI
RP   ECOTIN, ACTIVE SITE, AND DISULFIDE BONDS.
RX   PubMed=10966646; DOI=10.1038/78992;
RA   Waugh S.M., Harris J.L., Fletterick R., Craik C.S.;
RT   "The structure of the pro-apoptotic protease granzyme B reveals the
RT   molecular determinants of its specificity.";
RL   Nat. Struct. Biol. 7:762-765(2000).
CC   -!- FUNCTION: Abundant protease in the cytosolic granules of cytotoxic T-
CC       cells and NK-cells which activates caspase-independent pyroptosis when
CC       delivered into the target cell through the immunological synapse (By
CC       similarity). It cleaves after Asp (PubMed:9765264). Once delivered into
CC       the target cell, acts by catalyzing cleavage of gasdermin-E (GSDME),
CC       releasing the pore-forming moiety of GSDME, thereby triggering
CC       pyroptosis and target cell death (By similarity). Seems to be linked to
CC       an activation cascade of caspases (aspartate-specific cysteine
CC       proteases) responsible for apoptosis execution (By similarity). Cleaves
CC       caspase-3 and -9 (CASP3 and CASP9, respectively) to give rise to active
CC       enzymes mediating apoptosis (PubMed:9765264). Cleaves and activates
CC       CASP7 in response to bacterial infection, promoting plasma membrane
CC       repair (By similarity). {ECO:0000250|UniProtKB:P04187,
CC       ECO:0000250|UniProtKB:P10144, ECO:0000269|PubMed:9765264}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Preferential cleavage: -Asp-|-Xaa- >> -Asn-|-Xaa- > -Met-|-
CC         Xaa-, -Ser-|-Xaa-.; EC=3.4.21.79;
CC         Evidence={ECO:0000269|PubMed:9765264};
CC   -!- ACTIVITY REGULATION: Inactivated by the serine protease inhibitor
CC       diisopropylfluorophosphate. {ECO:0000250|UniProtKB:P10144}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:9765264}. Cytolytic
CC       granule {ECO:0000250|UniProtKB:P10144}. Note=Delivered into the target
CC       cell by perforin. {ECO:0000250|UniProtKB:P10144}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. Granzyme subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M34097; AAA42055.1; -; mRNA.
DR   PIR; A43520; A43520.
DR   RefSeq; NP_612526.2; NM_138517.3.
DR   RefSeq; XP_002728303.2; XM_002728257.5.
DR   RefSeq; XP_017460403.1; XM_017604914.1.
DR   PDB; 1FI8; X-ray; 2.20 A; A/B=21-248.
DR   PDBsum; 1FI8; -.
DR   AlphaFoldDB; P18291; -.
DR   SMR; P18291; -.
DR   IntAct; P18291; 1.
DR   STRING; 10116.ENSRNOP00000040429; -.
DR   MEROPS; S01.091; -.
DR   PhosphoSitePlus; P18291; -.
DR   PaxDb; 10116-ENSRNOP00000040429; -.
DR   Ensembl; ENSRNOT00000041430.6; ENSRNOP00000040429.3; ENSRNOG00000049976.3.
DR   Ensembl; ENSRNOT00055020726; ENSRNOP00055016714; ENSRNOG00055012185.
DR   Ensembl; ENSRNOT00060029104; ENSRNOP00060023430; ENSRNOG00060017012.
DR   Ensembl; ENSRNOT00065053603; ENSRNOP00065044053; ENSRNOG00065031090.
DR   GeneID; 171528; -.
DR   KEGG; rno:171528; -.
DR   UCSC; RGD:620018; rat.
DR   AGR; RGD:620018; -.
DR   CTD; 3002; -.
DR   RGD; 620018; Gzmb.
DR   eggNOG; KOG3627; Eukaryota.
DR   GeneTree; ENSGT01030000234551; -.
DR   HOGENOM; CLU_006842_1_0_1; -.
DR   InParanoid; P18291; -.
DR   OMA; PAYNPEK; -.
DR   OrthoDB; 2540265at2759; -.
DR   PhylomeDB; P18291; -.
DR   TreeFam; TF333630; -.
DR   BRENDA; 3.4.21.79; 5301.
DR   Reactome; R-RNO-5620971; Pyroptosis.
DR   Reactome; R-RNO-75108; Activation, myristolyation of BID and translocation to mitochondria.
DR   EvolutionaryTrace; P18291; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000045973; Expressed in jejunum and 11 other cell types or tissues.
DR   ExpressionAtlas; P18291; baseline and differential.
DR   GO; GO:0044194; C:cytolytic granule; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:RGD.
DR   GO; GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0140507; P:granzyme-mediated programmed cell death signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031640; P:killing of cells of another organism; IEA:UniProtKB-KW.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; IDA:RGD.
DR   GO; GO:0060545; P:positive regulation of necroptotic process; IMP:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:0051603; P:proteolysis involved in protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0070269; P:pyroptotic inflammatory response; ISS:UniProtKB.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; ISO:RGD.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24271:SF81; GRANZYME B; 1.
DR   PANTHER; PTHR24271; KALLIKREIN-RELATED; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Cytolysis; Direct protein sequencing;
KW   Disulfide bond; Hydrolase; Lysosome; Protease; Reference proteome;
KW   Secreted; Serine protease; Signal; Zymogen.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..20
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000269|PubMed:1727874"
FT                   /id="PRO_0000027425"
FT   CHAIN           21..248
FT                   /note="Granzyme B"
FT                   /id="PRO_0000027426"
FT   DOMAIN          21..246
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        65
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000269|PubMed:10966646"
FT   ACT_SITE        109
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000269|PubMed:10966646"
FT   ACT_SITE        204
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000269|PubMed:10966646"
FT   SITE            229
FT                   /note="Mediates preference for Asp-containing substrates"
FT                   /evidence="ECO:0000269|PubMed:10966646"
FT   DISULFID        50..66
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274,
FT                   ECO:0000269|PubMed:10966646"
FT   DISULFID        143..210
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274,
FT                   ECO:0000269|PubMed:10966646"
FT   DISULFID        174..189
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274,
FT                   ECO:0000269|PubMed:10966646"
FT   MUTAGEN         102
FT                   /note="N->Q: Decreased secretion without affecting the
FT                   protease activity."
FT                   /evidence="ECO:0000269|PubMed:9765264"
FT   MUTAGEN         229
FT                   /note="R->A: Does not affect the protease activity."
FT                   /evidence="ECO:0000269|PubMed:9765264"
FT   MUTAGEN         229
FT                   /note="R->E: Decreased activity for acidic amino acids at
FT                   position P3, whereas the activity against basic amino is
FT                   increased."
FT                   /evidence="ECO:0000269|PubMed:9765264"
FT   CONFLICT        98
FT                   /note="H -> F (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        138
FT                   /note="K -> D (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          35..41
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          49..56
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   HELIX           64..66
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          69..76
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          88..97
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   TURN            103..106
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          111..117
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          162..168
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   HELIX           171..177
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   TURN            178..181
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   TURN            184..186
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          187..191
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          206..210
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          213..222
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   STRAND          229..233
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   HELIX           234..237
FT                   /evidence="ECO:0007829|PDB:1FI8"
FT   HELIX           238..245
FT                   /evidence="ECO:0007829|PDB:1FI8"
SQ   SEQUENCE   248 AA;  27326 MW;  6F52089DDACCC88C CRC64;
     MKLLLLLLSF SLAPKTEAGE IIGGHEAKPH SRPYMAYLQI MDEYSGSKKC GGFLIREDFV
     LTAAHCSGSK INVTLGAHNI KEQEKMQQII PVVKIIPHPA YNSKTISNDI MLLKLKSKAK
     RSSAVKPLNL PRRNVKVKPG DVCYVAGWGK LGPMGKYSDT LQEVELTVQE DQKCESYLKN
     YFDKANEICA GDPKIKRASF RGDSGGPLVC KKVAAGIVSY GQNDGSTPRA FTKVSTFLSW
     IKKTMKKS
//
